Nimmi Ramanujam

Employment

• Calla Health Foundation Founder
  2019 - Present
• Duke University Professor
  2014 - Present
• Center for Global Women’s Health Technologies Director and Founder
  2013 - Present
• Duke Global Health Institute Professor
  2013 - Present
• Duke University Professor
  2011 - Present
• Zenalux Biomedical (previously known as Ends Optics Inc.), Founder
  2006 - Present
• Duke University Associate Professor
  2005 - 2010
• University of Wisconsin Madison Assistant Professor
  2000 - 2005
• University of Pennsylvania Assistant Professor
  1999 - 2000
• University of Pennsylvania National Institutes of Health postdoctoral Fellow
  1996 - 1996
• University of Texas at Austin Department of Biomedical Engineering Research Scientist,
  1995 - 1996

Education

• University of Texas System Ph.D. Biomedical Engineering
  ? - 1995

Projects & Funding

Projects & funding information is unavailable.

Publications (175)

• In vivo imaging of metabolic heterogeneity across three endpoints relevant to aggressive breast cancer
  PNAS Nexus 2026 DOI: 10.1093/pnasnexus/pgag027
  +Save
• Data from: In vivo imaging of metabolic heterogeneity across three endpoints relevant to aggressive breast cancer
  Duke Research Data Repository 2025 DOI: 10.7924/r4z32354z
  +Save
• A color‐based tumor segmentation method for clinical ex vivo breast tissue assessment utilizing a multi‐contrast brightfield imaging strategy
  Journal of Biophotonics 2024 DOI: 10.1002/jbio.202300241
  +Save
• Impact of Injection-Based Delivery Parameters on Local Distribution Volume of Ethyl-Cellulose Ethanol Gel in Tissue and Tissue Mimicking Phantoms
  IEEE Transactions on Biomedical Engineering 2024 DOI: 10.1109/TBME.2023.3340613
  +Save
• Metabolic Imaging as a Tool to Characterize Chemoresistance and Guide Therapy in Triple-Negative Breast Cancer (TNBC)
  Molecular Cancer Research 2023 DOI: 10.1158/1541-7786.MCR-22-1004
  +Save
• Locoregional Thermal and Chemical Tumor Ablation: Review of Clinical Applications and Potential Opportunities for Use in Low- and Middle-Income Countries
  JCO Global Oncology 2023 DOI: 10.1200/GO.23.00155
  +Save
• A color-based tumor segmentation method for clinical ex vivo breast tissue assessment utilizing a multi-contrast brightfield imaging strategy
  2023 DOI: 10.22541/au.168750561.17571307/v1
  +Save
• Feasibility and Outcome of Training Field Workers to Use the Transvaginal Colposcope for Point of Care Diagnosis and Management of Precancerous Cervical Lesions
  Indian Journal of Gynecologic Oncology 2023 DOI: 10.1007/s40944-022-00681-6
  +Save
• Evaluation of Women's Empowerment in a Community-Based Human Papillomavirus Self-Sampling Social Entrepreneurship Program (Hope Project) in Peru: A Mixed-Method Study
  OpenAlex 2022 DOI: 10.60692/hgf9z-05585
  +Save
• Evaluation of Women's Empowerment in a Community-Based Human Papillomavirus Self-Sampling Social Entrepreneurship Program (Hope Project) in Peru: A Mixed-Method Study
  OpenAlex 2022 DOI: 10.60692/wmstz-m5k16
  +Save